Bausch Health Companies Quarterly Cash Flow Statement
NYSE: BHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bausch Health Companies free cash flow
In the quarter ended Jun 30, 2026, Bausch Health Companies generated $670.0 million of operating cash flow and spent $77.0 million on capital expenditures. That left free cash flow of $593.0 million, a free-cash-flow margin of 20.8% of revenue. Free cash flow was up 212.1% from the prior year's $190.0 million.
Summary generated from market data by MetaCap's automated system. Methodology
Bausch Health Companies cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 260.00M | -1.43B | -103.00M | 181.00M | 128.00M | -86.00M | 98.00M | -92.00M | -1.00M | -77.00M | -47.00M | -382.00M |
| Net Income growth (YoY) | +103.13% | — | -205.10% | — | — | — | — | — | -103.70% | — | — | -194.79% |
| Depreciation & Amortization | 281.00M | 295.00M | 290.00M | 306.00M | 307.00M | 305.00M | 307.00M | 322.00M | 318.00M | 320.00M | 329.00M | 301.00M |
| Stock-Based Compensation | 54.00M | 52.00M | 84.00M | 43.00M | 46.00M | 43.00M | 43.00M | 38.00M | 36.00M | 33.00M | 29.00M | 29.00M |
| Change in Working Capital | 17.00M | -43.00M | -192.00M | -53.00M | 91.00M | -65.00M | -116.00M | 126.00M | 32.00M | -35.00M | -170.00M | -148.00M |
| Operating Cash Flow | 670.00M | 230.00M | 495.00M | 405.00M | 289.00M | 211.00M | 601.00M | 405.00M | 380.00M | 211.00M | 390.00M | 282.00M |
| Capital Expenditures | -77.00M | -109.00M | -92.00M | -91.00M | -99.00M | -115.00M | -106.00M | -71.00M | -78.00M | -82.00M | -98.00M | -42.00M |
| Investing Cash Flow | -93.00M | -139.00M | -282.00M | -83.00M | -100.00M | -130.00M | -200.00M | -102.00M | -79.00M | -73.00M | -148.00M | -1.89B |
| Debt Issued | 84.00M | 2.80B | 133.00M | -1.00M | 10.37B | 50.00M | 506.00M | 0 | 80.00M | 75.00M | 146.00M | 2.69B |
| Debt Repaid | -112.00M | -2.86B | -352.00M | -704.00M | -9.97B | -168.00M | -411.00M | -164.00M | -495.00M | -390.00M | -203.00M | -817.00M |
| Financing Cash Flow | -49.00M | -100.00M | -235.00M | -719.00M | 358.00M | -146.00M | 85.00M | -189.00M | -424.00M | -340.00M | -79.00M | 1.82B |
| Net Change in Cash | 526.00M | -13.00M | -15.00M | -403.00M | 586.00M | -44.00M | 451.00M | 127.00M | -132.00M | -207.00M | 182.00M | 192.00M |
| Free Cash Flow | 593.00M | 121.00M | 403.00M | 314.00M | 190.00M | 96.00M | 495.00M | 334.00M | 302.00M | 129.00M | 292.00M | 240.00M |
This table shows 12 quarterly periods of Bausch Health Companies's cash flow statement, from Q2 2026 back to Q3 2023, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow BHC's reporting calendar. What is a cash flow statement?